Helena Yu, MD

Author

Latest Videos
How to Choose the Best First-Line Therapy for Patients With EGFR-Mutated NSCLC

Video

How to Choose the Best First-Line Therapy for Patients With EGFR-Mutated NSCLC

Susan Scott, MD | Estelamari Rodriguez, MD, MPH | Helena Yu, MD

New Insights From the MARIPOSA Trial: Amivantamab Plus Lazertinib for EGFR-Mutated NSCLC

Video

New Insights From the MARIPOSA Trial: Amivantamab Plus Lazertinib for EGFR-Mutated NSCLC

Helena Yu, MD | Joshua Sabari, MD

Targeted Therapies in EGFR-Mutated NSCLC: Managing Treatment-Related AEs

Video

Targeted Therapies in EGFR-Mutated NSCLC: Managing Treatment-Related AEs

Estelamari Rodriguez, MD, MPH | Helena Yu, MD | Joshua Sabari, MD